GRP
MLTX icon

Global Retirement Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History

Global Retirement Partners’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$13 Buy
+1
New +$12 ﹤0.01% 4210

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Global Retirement Partners's MLTX Position: Q4 2025 in Review

Global Retirement Partners opened a new position in MoonLake Immunotherapeutics (MLTX) in Q4 2025: 1 share worth $13. The stake represents ﹤0.01% of the portfolio and ranks #4210 among its holdings.

130 funds tracked by Wall St. Rank hold MLTX as of Q4 2025.

  • Global Retirement Partners held 1 share of MoonLake Immunotherapeutics worth $13 as of Q4 2025.
  • MoonLake Immunotherapeutics was a new Global Retirement Partners position in Q4 2025.
  • MoonLake Immunotherapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #4210 holding.
  • 130 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.